《中国成人T细胞淋巴母细胞淋巴瘤诊断与治疗专家共识（2023年版）》 - Suppr

Suppr

超能文献

[The consensus of the diagnosis and treatment of adult T-cell lymphoblastic lymphoma in China (2023)].

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2023 May 14;44(5):353-358. doi: 10.3760/cma.j.issn.0253-2727.2023.05.001.

DOI:10.3760/cma.j.issn.0253-2727.2023.05.001

PMID:37550183

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10440620/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcdf/10440620/1bc18d9bc07d/cjh-44-05-353-g001.jpg

相似文献

[The consensus of the diagnosis and treatment of adult T-cell lymphoblastic lymphoma in China (2023)].《中国成人T细胞淋巴母细胞淋巴瘤诊断与治疗专家共识（2023年版）》

Zhonghua Xue Ye Xue Za Zhi. 2023 May 14;44(5):353-358. doi: 10.3760/cma.j.issn.0253-2727.2023.05.001.

Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma.成人T细胞淋巴母细胞淋巴瘤的基因组与预后分析

Haematologica. 2020 Mar;105(3):e107-e110. doi: 10.3324/haematol.2019.220863. Epub 2019 Aug 14.

Dismal outcome of relapsed or primary refractory adult T-cell lymphoblastic lymphoma: A retrospective study from China.复发或原发性难治性成人 T 细胞淋巴母细胞淋巴瘤的不良结局：来自中国的回顾性研究。

Asia Pac J Clin Oncol. 2022 Apr;18(2):e87-e95. doi: 10.1111/ajco.13562. Epub 2021 Jun 23.

[Chinese expert consensus on diagnosis and treatment of adult early T cell precursor acute lymphoblastic leukemia (2023)].《成人早期T细胞前体急性淋巴细胞白血病诊断与治疗中国专家共识（2023年版）》

Zhonghua Xue Ye Xue Za Zhi. 2023 Dec 14;44(12):977-982. doi: 10.3760/cma.j.issn.0253-2727.2023.12.002.

Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults.儿童、青少年及青年淋巴细胞性淋巴瘤的诊断与治疗。

Best Pract Res Clin Haematol. 2023 Mar;36(1):101449. doi: 10.1016/j.beha.2023.101449. Epub 2023 Feb 16.

A Novel Case of Concurrent T-cell and Early T-cell Precursor Lymphoblastic Lymphoma in an Adolescent Female.一例青少年女性同时患有 T 细胞和早期 T 细胞前体细胞淋巴母细胞淋巴瘤。

J Pediatr Hematol Oncol. 2022 Mar 1;44(2):e550-e553. doi: 10.1097/MPH.0000000000002257.

SOHO State of the Art Updates and Next Questions | Novel Approaches to Pediatric T-cell ALL and T-Lymphoblastic Lymphoma.SOHO 最新进展及未来展望 | 儿童 T 细胞急性淋巴细胞白血病和 T 淋巴母细胞淋巴瘤的新方法。

Clin Lymphoma Myeloma Leuk. 2022 Oct;22(10):718-725. doi: 10.1016/j.clml.2022.07.010. Epub 2022 Jul 20.

International Consensus Classification of acute lymphoblastic leukemia/lymphoma.国际急性淋巴细胞白血病/淋巴瘤分类共识。

Virchows Arch. 2023 Jan;482(1):11-26. doi: 10.1007/s00428-022-03448-8. Epub 2022 Nov 24.

[Clinical Features and Prognosis of Acute T-cell Lymphoblastic Leukemia in Children--Multi-Center Data Analysis in Fujian].[儿童急性T淋巴细胞白血病的临床特征与预后——福建多中心数据分析]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Feb;32(1):6-13. doi: 10.19746/j.cnki.issn.1009-2137.2024.01.002.

Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma.开发针对T细胞急性淋巴细胞白血病/淋巴瘤的靶向疗法。

Curr Hematol Malig Rep. 2023 Dec;18(6):217-225. doi: 10.1007/s11899-023-00706-7. Epub 2023 Jul 25.

本文引用的文献

Current status and prospects of hematopoietic stem cell transplantation in China.中国造血干细胞移植的现状与展望。

Chin Med J (Engl). 2022 Jun 20;135(12):1394-1403. doi: 10.1097/CM9.0000000000002235.

Unity brings strength: Combination of CAR-T cell therapy and HSCT.团结就是力量：CAR-T 细胞疗法与 HSCT 的联合应用。

Cancer Lett. 2022 Nov 28;549:215721. doi: 10.1016/j.canlet.2022.215721. Epub 2022 May 7.

Naturally selected CD7 CAR-T therapy without genetic manipulations for T-ALL/LBL: first-in-human phase 1 clinical trial.未经基因操作的自然选择 CD7 CAR-T 疗法治疗 T-ALL/LBL：首例人体 I 期临床试验。

Blood. 2022 Jul 28;140(4):321-334. doi: 10.1182/blood.2021014498.

Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma.自体纳米抗体衍生的杀伤细胞自身稳定嵌合抗原受体 T 细胞疗法治疗复发/难治性 T 细胞急性淋巴细胞白血病/淋巴瘤患者。

Clin Cancer Res. 2022 Jul 1;28(13):2830-2843. doi: 10.1158/1078-0432.CCR-21-4097.

Survival and prognostic analysis of T-cell lymphoblastic lymphoma patients treated with dose-adjusted BFM-90 regimen.调整剂量 BFM-90 方案治疗 T 细胞淋巴母细胞淋巴瘤患者的生存和预后分析。

Aging (Albany NY). 2022 Apr 10;14(7):3203-3215. doi: 10.18632/aging.204008.

Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.维奈克拉用于治疗儿童和青少年急性淋巴细胞白血病和淋巴细胞淋巴瘤。

Cancers (Basel). 2021 Dec 29;14(1):150. doi: 10.3390/cancers14010150.

Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.维奈托克和纳武利尤单抗联合化疗治疗复发或难治性急性淋巴细胞白血病和淋巴母细胞淋巴瘤患者。

Cancer Discov. 2021 Jun;11(6):1440-1453. doi: 10.1158/2159-8290.CD-20-1465. Epub 2021 Feb 16.

Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study.在 118 例复发/难治性 T 细胞急性淋巴细胞白血病/淋巴瘤成人患者中，用奈拉滨作为挽救性治疗和异基因干细胞移植的桥接治疗。CAMPUS ALL 研究。

Am J Hematol. 2020 Dec;95(12):1466-1472. doi: 10.1002/ajh.25957. Epub 2020 Aug 31.

BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphoma.BRD2 通过激活 RasGRP1/Ras/ERK 信号通路诱导成人 T 细胞淋巴母细胞淋巴瘤的耐药性。

Cancer Commun (Lond). 2020 Jun;40(6):245-259. doi: 10.1002/cac2.12039. Epub 2020 May 27.

Clinicopathological Characteristics and Mutational Profiling of Adult T-Cell Lymphoblastic Lymphoma in a Chinese Population.中国人群中成人T细胞淋巴母细胞淋巴瘤的临床病理特征及突变谱分析

Cancer Manag Res. 2020 Apr 30;12:3003-3012. doi: 10.2147/CMAR.S242903. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验